Neuralink, Elon Musk's brain-implant firm, is set to launch a trial in October designed to aid individuals with speech impairments by translating thoughts into text. President Dongjin “D.J.” Seo announced at a tech institute in Seoul that the device, granted a Breakthrough Device designation by the FDA, can facilitate direct brain-to-voice conversion. This follows successful human trials initiated in 2024, allowing patients to utilize the chip for various activities, impacting communication for many.
Neuralink, Elon Musk's brain-implant firm, is set to launch a trial in October designed to aid individuals with speech impairments by translating thoughts into text. President Dongjin “D.J.” Seo announced at a tech institute in Seoul that the device, granted a Breakthrough Device designation by the FDA, can facilitate direct brain-to-voice conversion. This follows successful human trials initiated in 2024, allowing patients to utilize the chip for various activities, impacting communication for many.